Inventor · disambiguated record
Hairuo Peng
Also filed as: PENG HAIRUO
18 granted patents·7 pending applications·69 citations·filing 1998–2022
92Inventor score
Top patents by PatentIndex Score
25 records- 0188US9771326B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Sep 26, 2017·6 cites·11 claims
- 0286US9550798B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Jan 24, 2017·8 cites·25 claims
- 0384US9850206B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 26, 2017·4 cites·22 claims
- 0484US7968536B2Heterocyclic compounds useful as RAF kinase inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted Jun 28, 2011·9 cites·31 claims
- 0582US9522889B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 20, 2016·5 cites·31 claims
- 0681US9556177B2Substituted 1,3-thiazoles as synthetic intermediates for preparation of Raf kinase inhibitorsMILLENNIUM PHARM INC·Filed 2014·Granted Jan 31, 2017·4 cites·18 claims
- 0781US8802657B2Compounds useful as Raf kinase inhibitorsMILLENNIUM PHARM INC·Filed 2012·Granted Aug 12, 2014·4 cites·19 claims
- 0880US8293752B2Compounds useful as Raf kinase inhibitorsCHEN WEIRONG·Filed 2008·Granted Oct 23, 2012·6 cites·13 claims
- 0977US7834014B2A2a adenosine receptor antagonistsBIOGEN IDEC INC·Filed 2004·Granted Nov 16, 2010·10 cites·27 claims
- 1073US7674791B2Triazolopyrazines and methods of making and using the sameBIOGEN IDEC INC·Filed 2004·Granted Mar 9, 2010·7 cites·13 claims
- 1168US9765016B2S1P modulating agentsBIOGEN MA INC·Filed 2014·Granted Sep 19, 2017·1 cites·18 claims
- 1266US7763620B2Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatmentUNIV YALE·Filed 2002·Granted Jul 27, 2010·2 cites·15 claims
- 1363US2025197375A1Pyrimidines and methods of their useKINETA INC·Filed 2022·Application pending·0 cites
- 1462US2025353852A1Compounds and compositions that inhibit pikfyveKINETA INC·Filed 2022·Application pending·0 cites
- 1562US2025353851A1Purines and methods of their useKINETA INC·Filed 2022·Application pending·0 cites
- 1660US2025288589A1Pyridopyrimidines and methods of their useKINETA INC·Filed 2022·Application pending·0 cites
- 1760US2025145642A1Bicyclic heteroarenes and methods of their useKINETA INC·Filed 2022·Application pending·0 cites
- 1855US9920048B2Substituted pyrimidines for inhibiting Raf kinase activityMILLENNIUM PHARM INC·Filed 2016·Granted Mar 20, 2018·0 cites·13 claims
- 1952US2016039825A1S1p and/or atx modulating agentsBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 2050US2012040951A1Heteroaryl compounds useful as raf kinase inhibitorsCHUAQUI CLAUDIO·Filed 2009·Application pending·0 cites
- 2148US9944666B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2016·Granted Apr 17, 2018·0 cites·15 claims
- 2247US10017506B2ATX modulating agentsBIOGEN MA INC·Filed 2016·Granted Jul 10, 2018·0 cites·21 claims
- 2337US6011058ASeco-cholestane derivatives and methods of making the sameGEORGIA TECH RES INST·Filed 1998·Granted Jan 4, 2000·3 cites·48 claims
- 2436US10144732B2ATX modulating agentsBIOGEN MA INC·Filed 2015·Granted Dec 4, 2018·0 cites·21 claims
- 2529US9963462B2Sepiapterin reductase inhibitorsQUARTET MEDICINE INC·Filed 2016·Granted May 8, 2018·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Hairuo Peng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →